U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
ROVALPITUZUMAB TESIRINE
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
rovalpituzumab tesirine [INN]
Common Name English
SC-002 [WHO-DD]
Code English
SC16LD6.5-ADC
Code English
SC0002
Code English
IMMUNOGLOBULIN G1, ANTI-(PROTEIN DLL3 (DELTA-LIKE LIGAND 3)) (HUMAN-MUS MUSCULUS MONOCLONAL SC0001 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SC0001 .KAPPA.-CHAIN, DIMER, THIOETHER WITH N-(31-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1,29-DIO
Common Name English
ROVALPITUZUMAB TESIRINE [USAN]
Common Name English
SC-16LD6.5
Code English
SC-002
Code English
SC16LD6.5
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 500315
Created by admin on Sat Dec 16 10:12:25 GMT 2023 , Edited by admin on Sat Dec 16 10:12:25 GMT 2023
EU-Orphan Drug EU/3/16/1667
Created by admin on Sat Dec 16 10:12:25 GMT 2023 , Edited by admin on Sat Dec 16 10:12:25 GMT 2023
Code System Code Type Description
USAN
DE-143
Created by admin on Sat Dec 16 10:12:25 GMT 2023 , Edited by admin on Sat Dec 16 10:12:25 GMT 2023
PRIMARY
CAS
1613313-09-9
Created by admin on Sat Dec 16 10:12:25 GMT 2023 , Edited by admin on Sat Dec 16 10:12:25 GMT 2023
PRIMARY
WIKIPEDIA
Rovalpituzumab tesirine
Created by admin on Sat Dec 16 10:12:25 GMT 2023 , Edited by admin on Sat Dec 16 10:12:25 GMT 2023
PRIMARY
DRUG BANK
DB13017
Created by admin on Sat Dec 16 10:12:25 GMT 2023 , Edited by admin on Sat Dec 16 10:12:25 GMT 2023
PRIMARY
INN
10141
Created by admin on Sat Dec 16 10:12:25 GMT 2023 , Edited by admin on Sat Dec 16 10:12:25 GMT 2023
PRIMARY
EVMPD
SUB181948
Created by admin on Sat Dec 16 10:12:25 GMT 2023 , Edited by admin on Sat Dec 16 10:12:25 GMT 2023
PRIMARY
NCI_THESAURUS
C107678
Created by admin on Sat Dec 16 10:12:25 GMT 2023 , Edited by admin on Sat Dec 16 10:12:25 GMT 2023
PRIMARY
FDA UNII
P256HB60FF
Created by admin on Sat Dec 16 10:12:25 GMT 2023 , Edited by admin on Sat Dec 16 10:12:25 GMT 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966